Gliosarcoma - 27 Studies Found Recruiting : Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma : Gliosarcoma Supratentorial Glioblastoma : 2014-12-08 : Biological: Ipilimumab Given I Completed : Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme : Glioblastoma Multiforme Gliosarcoma : 2009-09-15 : Drug: Avastin Avastin, by intr Completed : Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors : Glioblastoma Multiforme Gliosarcoma : 2005-09-13 : Drug: Tarceva Tarceva (erlotin Completed : Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma : Adult Giant Cell Glioblastoma Adult Glioblastoma Adult : 2006-06-08 : Drug: sorafenib tosylate given Active, not recruiting : Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma : Giant Cell Glioblastoma Glioblastoma : 2010-06-22 : Biological: bevacizumab Given Completed : Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma : Adult Glioblastoma Adult Gliosarcoma Drug: irinotecan hydrochloride Completed : Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma : Adult Giant Cell Glioblastoma Adult Glioblastoma Adult : 2002-11-12 : Drug: tipifarnib Given PO Completed : Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma : Adult Giant Cell Glioblastoma Adult Glioblastoma Adult : 2006-03-21 : Radiation: 3-dimensional conformal radiation therapy Terminated : Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma : Adult Brain Tumors : 2006-10-12 : Drug: erlotinib hydrochloride Tarceva will be self-administered in an open-label, unblinded manner to al Enrolling by invitation : Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 : Glioblastoma : 2015-04-23 : Drug: MK - 3475 Administered I <<< Previous | Next >>>